Strides for Life I: Increasing Physical Activity in Stage 1 Lung Cancer Patients

Study summary

This randomized controlled trial will evaluate, among 54 stage early stage lung cancer patients, whether a behavioral intervention versus an educational Control group results in improved function at 6-months.

Ask AI to explain this study

Start here

Key things to know

Main goalPrevention

This describes the study’s primary purpose.

What is being studiedPhysical activity plus positive affect and Physical activity plus education

The study team can explain what participation involves.

Who it may be forEarly-stage or resectable

These are broad labels—not an eligibility decision.

Checked against the public recordLast updated Feb 7, 2018 · Source: ClinicalTrials.gov

Is enrollment open?Completed

Ask the study team to confirm whether enrollment is open.

What kind of study?Not applicable

Interventional

Where is it offered?1 U.S. location

Locations may change over time.

Who runs it?Weill Medical College of Cornell University

Study sponsor

Study overview

What this study is about

Purpose: Prevention
Study type: Interventional
Phase: Not applicable
Sponsor: Weill Medical College of Cornell University
Interventions being studied: Behavioral: Physical activity plus positive affect; Behavioral: Physical activity plus education

Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

Disease setting

Early-stage or resectable→

Treatment approach

Supportive or behavioral care→

Public criteria

Who may be able to participate

The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.

Requirements people may need to meetInclusion criteria

Non-small cell lung cancer (Stage 1)

Reasons someone may not be able to joinExclusion criteria

1. Cognitive impairment 2. Inability to walk 3. \< 12 month anticipated survival 4. enrollment in other behavioral programs 5. lack of medical approval to participate 6. substance/alcohol dependence or participation in a substance abuse treatment program within 12 months 7. major psychiatric illness.

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

Study sites

U.S. locations

Weill Cornell Medical CollegeNew York, New York

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Feb 7, 2018. Always confirm current availability with the study team.

View original record ↗